Centessa Pharmaceuticals Stock (NASDAQ: CNTA) stock price, news, charts, stock research, profile.
Open | $10.000 |
Close | $9.400 |
Volume / Avg. | 200.077K / 392.083K |
Day Range | 9.370 - 10.170 |
52 Wk Range | 3.960 - 12.450 |
Market Cap | $958.924M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 2.35% |
Days to Cover | 6.67 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Centessa Pharmaceuticals (NASDAQ: CNTA) through any online brokerage.
Other companies in Centessa Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL) and Prothena Corp (NASDAQ:PRTA).
The latest price target for Centessa Pharmaceuticals (NASDAQ: CNTA) was reported by BMO Capital on Monday, April 1, 2024. The analyst firm set a price target for 15.00 expecting CNTA to rise to within 12 months (a possible 56.90% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Centessa Pharmaceuticals (NASDAQ: CNTA) is $9.56 last updated April 23, 2024 at 7:53 PM EDT.
There are no upcoming dividends for Centessa Pharmaceuticals.
Centessa Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Centessa Pharmaceuticals.
Centessa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.